A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent selected from a JNK inhibitor, a TRPV modulator, a MET channel inhibitor, and an otoprotectant to the individual in need thereof, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
Quick reference: recommended water volumes by vial size Here is the summary table
Some in-person weight loss programs, especially those through hospitals, offer discounts or income-based pricing
premium one-on-one coaching at $49.99/month includes two 20-minute sessions per month via video, phone, or text Clinical Note on Oral Formats: ShedRx offers oral compounded formats, but doesnt clearly explain how these differ clinically from injectables
During this window, simply inject as soon as you remember
PMID: 14523363
